Advertisement

Topics

Brexit is Costly, UK Drugmakers say

03:02 EDT 13 Jun 2018 | CHEManager

Uncertainty about the effects of Brexit on the pharmaceuticals sector is forcing British drugmakers to invest hundreds of millions of pounds to maintain the steady supply of medicines to patients, according to the Association of the British Pharmaceutical Industry.

Original Article: Brexit is Costly, UK Drugmakers say

NEXT ARTICLE

More From BioPortfolio on "Brexit is Costly, UK Drugmakers say"

Advertisement
Quick Search
Advertisement
Advertisement